What is the appropriate management for a patient with a serum sodium of 120 mEq/L?

Management of Serum Sodium 120 mEq/L

For a patient with sodium of 120 mEq/L, immediately assess symptom severity and volume status: if severely symptomatic (seizures, altered mental status, coma), administer 100 mL of 3% hypertonic saline as an IV bolus over 10 minutes, targeting a 4-6 mEq/L increase within the first 1-2 hours; if asymptomatic or mildly symptomatic, determine volume status and treat the underlying cause with a maximum correction rate of 8-10 mEq/L per 24 hours. 1, 2, 3

Immediate Assessment

Symptom Severity Classification

• Severe symptoms include seizures, coma, somnolence, obtundation, or cardiorespiratory distress—these indicate hyponatremic encephalopathy requiring emergency treatment 1, 2
• Mild symptoms include nausea, vomiting, headache, confusion, or muscle aches 1
• Asymptomatic patients may still have cognitive impairment and increased fall risk even at this sodium level 4, 2

Volume Status Determination

Categorize the patient as hypovolemic, euvolemic, or hypervolemic based on: 1

• Physical examination: skin turgor, mucous membranes, jugular venous pressure, peripheral edema, orthostatic vital signs
• Laboratory values: urine sodium (>40 mEq/L suggests renal losses; <20 mEq/L suggests extrarenal losses), urine osmolality
• Invasive monitoring when available (central venous pressure) 1

Treatment Based on Symptom Severity

Severely Symptomatic Hyponatremia (Medical Emergency)

Administer 3% hypertonic saline immediately: 1, 2, 3

• Give 100-150 mL as IV bolus over 10 minutes, repeat up to 2-3 times if severe symptoms persist 2, 5
• Target: increase sodium by 4-6 mEq/L within 1-2 hours to reverse cerebral edema 1, 2, 3
• Critical limit: do NOT exceed 8-10 mEq/L correction in first 24 hours 1, 2, 3
• Check serum sodium every 2 hours during active treatment 1
• Transfer to ICU for continuous monitoring 1

Recent evidence shows faster correction may reduce mortality, but osmotic demyelination risk remains real: A 2026 retrospective study of 13,988 patients found faster correction (>12 mEq/L per 24 hours) associated with lower 90-day mortality compared to slow correction (<8 mEq/L), with risk difference of -9.0 percentage points 6. However, international expert consensus strongly cautions against abandoning current safeguards, emphasizing that overcorrection can cause irreversible osmotic demyelination syndrome with quadriparesis, parkinsonism, or death 7, 8. The safest approach remains targeting 4-6 mEq/L increase for symptom resolution, then slowing to avoid exceeding 8-10 mEq/L total in 24 hours. 2, 3, 7

Mildly Symptomatic or Asymptomatic Hyponatremia

If Hypovolemic (Dehydration, Diuretics, Cerebral Salt Wasting):

• Stop diuretics if contributing 4
• Administer 0.9% normal saline for volume repletion 4
• In neurosurgical patients with cerebral salt wasting, add fludrocortisone 0.1-0.2 mg daily for 7 days 1
• Monitor sodium every 4-6 hours initially 1, 4

If Euvolemic (SIADH, Hypothyroidism, Adrenal Insufficiency):

• First-line: fluid restriction to 500-1000 mL/day 1, 8
• Rule out thyroid disease and hypocortisolism before diagnosing SIADH 1
• Second-line (if fluid restriction fails after 48 hours): oral urea 15-30 g/day or vaptans (tolvaptan) 2, 8
• Increase dietary salt and protein intake 8
• Monitor sodium daily until stable 4

If Hypervolemic (Heart Failure, Cirrhosis, Renal Failure):

• Continue standard therapy for underlying condition (diuretics for heart failure, etc.) 4
• Fluid restriction remains cornerstone 8
• Consider vaptans in refractory cases with high ADH activity 8
• Monitor closely as mild hyponatremia in cirrhosis indicates worsening hemodynamic status 4

Critical Correction Rate Limits

Maximum safe correction rates: 1, 2, 3, 7

• First 1-2 hours (severe symptoms only): 4-6 mEq/L increase to reverse cerebral edema
• First 24 hours: 8-10 mEq/L maximum total increase
• Chronic hyponatremia (>48 hours duration): do NOT exceed 8 mEq/L per 24 hours

If you correct 6 mEq/L in the first 6 hours for severe symptoms, you can only increase sodium by 2-4 mEq/L more over the remaining 18 hours. 1

Monitoring Protocol

Acute Phase (First 24 Hours):

• Check serum sodium every 2 hours during hypertonic saline administration 1
• Check serum sodium every 4 hours once symptoms resolve or if using normal saline 1, 5
• Monitor urine specific gravity every 4 hours to detect sudden water diuresis (decrease ≥0.010 from baseline signals risk of overcorrection) 5
• Track fluid input/output and daily weight 1
• Continuous neurological assessment 3

After Stabilization:

• Check sodium every 24-48 hours until stable at goal (>130 mEq/L) 4
• Continue monitoring electrolytes regularly if on diuretics 4

Common Pitfalls to Avoid

Overcorrection is the most dangerous complication: 2, 3, 7

• Correcting >10-12 mEq/L in 24 hours risks osmotic demyelination syndrome, which can cause irreversible quadriparesis, locked-in syndrome, or death
• Prevention: If overcorrection occurs or is imminent, immediately administer desmopressin (DDAVP) 2-4 mcg IV/SC and give hypotonic fluids (D5W) to re-lower sodium 3, 7

Using normal saline in SIADH worsens hyponatremia: 9

• Normal saline is appropriate only for hypovolemic hyponatremia
• In euvolemic SIADH, normal saline provides more sodium than the kidneys can retain, resulting in net water retention

Ignoring mild hyponatremia as "clinically insignificant": 4, 2

• Even sodium of 120 mEq/L without obvious symptoms increases fall risk, fracture risk, cognitive impairment, hospital length of stay, and mortality
• Always investigate and treat the underlying cause

Failing to monitor for water diuresis: 5

• Sudden improvement in underlying condition (e.g., stopping DDAVP, resolving nausea) can trigger rapid water diuresis and overcorrection
• Monitor urine output and specific gravity closely

Using 3% saline in asymptomatic patients: 9, 8

• Reserve hypertonic saline for severely symptomatic patients only
• Asymptomatic patients should receive slower, safer correction with fluid restriction and treatment of underlying cause